Studies on peroxisomes of colonic mucosa in Crohn's disease - PubMed (original) (raw)
. 1994 Oct;39(10):2177-85.
doi: 10.1007/BF02090368.
Affiliations
- PMID: 7924739
- DOI: 10.1007/BF02090368
Studies on peroxisomes of colonic mucosa in Crohn's disease
I Aimone-Gastin et al. Dig Dis Sci. 1994 Oct.
Abstract
The etiology and pathogenesis of Crohn's disease, a chronic inflammatory bowel pathology, have not been elucidated yet. In particular, the behavior of peroxisomes in inflamed colonic mucosa has not been investigated despite their important role in cellular oxidative metabolism. Using cytochemistry at the ultrastructural level, we have observed these catalase-positive organelles. In addition, biochemical analyses have revealed the specific activities of catalase and cyanide-insensitive acyl-CoA oxidase. Mucosal biopsy specimens from inflamed and noninflamed areas of Crohn's patients were compared to control biopsies. We found that Crohn's disease was marked by an important diminution in the peroxisomal frequency per cell unit area. If catalase activity was not affected by this pathology, cyanide-insensitive acyl-CoA oxidase, an enzyme of the peroxisomal beta-oxidation system, was found diminished in inflamed and in noninflamed areas. In conclusion, our results showed that Crohn's disease is accompanied by peroxisomal modifications but the number and the enzyme activities of colonic peroxisomes are less deeply altered in Crohn's disease than during neoplasia. This fact suggests that a relation may exist between the degree of peroxisomal deficiency and the clinical severity of colonic disease.
Similar articles
- Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis.
Minami T, Tojo H, Shinomura Y, Matsuzawa Y, Okamoto M. Minami T, et al. Gut. 1994 Nov;35(11):1593-8. doi: 10.1136/gut.35.11.1593. Gut. 1994. PMID: 7828979 Free PMC article. - Does active Crohn's disease have decreased intestinal antioxidant capacity?
Pinto MA, Lopes MS, Bastos ST, Reigada CL, Dantas RF, Neto JC, Luna AS, Madi K, Nunes T, Zaltman C. Pinto MA, et al. J Crohns Colitis. 2013 Oct;7(9):e358-66. doi: 10.1016/j.crohns.2013.02.010. Epub 2013 Mar 21. J Crohns Colitis. 2013. PMID: 23523266 - In situ heterogeneity of peroxisomal oxidase activities: an update.
Van den Munckhof RJ. Van den Munckhof RJ. Histochem J. 1996 Jun;28(6):401-29. doi: 10.1007/BF02331433. Histochem J. 1996. PMID: 8863047 Review. - [Peroxisomal beta-oxidation].
Mannaerts GP, Van Veldhoven PP. Mannaerts GP, et al. Verh K Acad Geneeskd Belg. 1993;55(1):45-78. Verh K Acad Geneeskd Belg. 1993. PMID: 8480447 Review. Dutch.
Cited by
- Altered gut transcriptome in spondyloarthropathy.
Laukens D, Peeters H, Cruyssen BV, Boonefaes T, Elewaut D, De Keyser F, Mielants H, Cuvelier C, Veys EM, Knecht K, Van Hummelen P, Remaut E, Steidler L, De Vos M, Rottiers P. Laukens D, et al. Ann Rheum Dis. 2006 Oct;65(10):1293-300. doi: 10.1136/ard.2005.047738. Epub 2006 Feb 13. Ann Rheum Dis. 2006. PMID: 16476712 Free PMC article. - Functional Analyses of the Crohn's Disease Risk Gene LACC1.
Assadi G, Vesterlund L, Bonfiglio F, Mazzurana L, Cordeddu L, Schepis D, Mjösberg J, Ruhrmann S, Fabbri A, Vukojevic V, Percipalle P, Salomons FA, Laurencikiene J, Törkvist L, Halfvarson J, D'Amato M. Assadi G, et al. PLoS One. 2016 Dec 13;11(12):e0168276. doi: 10.1371/journal.pone.0168276. eCollection 2016. PLoS One. 2016. PMID: 27959965 Free PMC article. - The Genetic Diversity and Dysfunctionality of Catalase Associated with a Worse Outcome in Crohn's Disease.
Iborra M, Moret I, Busó E, García-Giménez JL, Ricart E, Gisbert JP, Cabré E, Esteve M, Márquez-Mosquera L, García-Planella E, Guardiola J, Pallardó FV, Serena C, Algaba-Chueca F, Domenech E, Nos P, Beltrán B. Iborra M, et al. Int J Mol Sci. 2022 Dec 14;23(24):15881. doi: 10.3390/ijms232415881. Int J Mol Sci. 2022. PMID: 36555526 Free PMC article. - Crohn's disease: evidence for involvement of unregulated transcytosis in disease etio-pathogenesis.
Pravda J. Pravda J. World J Gastroenterol. 2011 Mar 21;17(11):1416-26. doi: 10.3748/wjg.v17.i11.1416. World J Gastroenterol. 2011. PMID: 21472099 Free PMC article. Review. - Catalase inhibition can modulate the ability of peripheral blood T cells to undergo apoptosis in Crohn's disease.
Moret-Tatay I, Nos P, Iborra M, Rausell F, Beltrán B. Moret-Tatay I, et al. Clin Exp Immunol. 2024 Jun 20;217(1):45-56. doi: 10.1093/cei/uxad134. Clin Exp Immunol. 2024. PMID: 38247555 Free PMC article.
References
- Mol Cell Biochem. 1988 Oct;83(2):187-94 - PubMed
- Surg Gynecol Obstet. 1991 Nov;173(5):343-9 - PubMed
- Gut. 1984 Apr;25(4):337-40 - PubMed
- Gastroenterology. 1985 Feb;88(2):580-7 - PubMed
- Gastroenterology. 1978 Oct;75(4):638-40 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical